These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29641497)

  • 1. Outcomes of Secondary Prevention among Coronary Heart Disease Patients in a High-Risk Region in Finland.
    Repo T; Tykkyläinen M; Mustonen J; Rissanen TT; Ketonen M; Toivakka M; Laatikainen T
    Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29641497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
    Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
    Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein (a) and coronary heart disease - is there an efficient secondary prevention?
    Mellwig KP; Horstkotte D; van Buuren F
    Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):18-21. PubMed ID: 28233270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin initiation following coronary artery bypass grafting: outcome of a hospital discharge protocol.
    Khanderia U; Townsend KA; Eagle K; Prager R
    Chest; 2005 Feb; 127(2):455-63. PubMed ID: 15705982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Secondary Prevention Status between Percutaneous Coronary Intervention and Coronary Artery Bypass Patients.
    Gao XQ; Li Y; Jiang ZL
    Arq Bras Cardiol; 2017 Nov; 109(5):466-474. PubMed ID: 29267627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the MAT-CHDSP to assess guideline adherence and therapy goal achievement in secondary prevention of coronary heart disease after percutaneous coronary intervention.
    Garcia BH; Småbrekke L; Trovik T; Giverhaug T
    Eur J Clin Pharmacol; 2013 Mar; 69(3):703-9. PubMed ID: 22990329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of depression in secondary prevention of Chinese coronary heart disease patients receiving percutaneous coronary intervention.
    Feng C; Ji T; Liu Y; Chen D; Dai J; Ni X; Zhu J; Liu X; Zhao X
    PLoS One; 2017; 12(12):e0187016. PubMed ID: 29267269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.
    Hu G; Cui Y; Jousilahti P; Sundvall J; Girman CJ; Antikainen R; Laatikainen T; Tuomilehto J
    Eur J Prev Cardiol; 2013 Feb; 20(1):89-97. PubMed ID: 22023802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
    Gitt AK; Lautsch D; Ferrières J; De Ferrari GM; Vyas A; Baxter CA; Bash LD; Ashton V; Horack M; Almahmeed W; Chiang FT; Poh KK; Brudi P; Ambegaonkar B
    Atherosclerosis; 2017 Nov; 266():158-166. PubMed ID: 29028484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential population impact of the UK government strategy for reducing the burden of coronary heart disease in England: comparing primary and secondary prevention strategies.
    Gemmell I; Heller RF; Payne K; Edwards R; Roland M; Durrington P
    Qual Saf Health Care; 2006 Oct; 15(5):339-43. PubMed ID: 17074870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate Level of Low-Density Lipoprotein Cholesterol for Secondary Prevention of Coronary Artery Disease.
    Naito R; Miyauchi K; Konishi H; Tsuboi S; Ogita M; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Daida H
    J Atheroscler Thromb; 2016; 23(4):413-21. PubMed ID: 26558399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A cross-sectional study on the treatment goals of blood pressure, serum lipids and blood glucose in elderly patients with coronary heart disease].
    Zhu Y; Wang J; Bao Y; Qiao YX; Wu LZ; Li J; Li J; Hu DY
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(21):1479-85. PubMed ID: 21914285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low-density lipoprotein cholesterol target goal attainment rate and related factors in patients with acute coronary syndrome after percutaneous coronary intervention].
    Zhang B; Dong X; Zhang Y; Huang R; Yin D; Zheng Z; Liu Y; Zhu H; Zhou X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):290-4. PubMed ID: 24924454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interhospital and interindividual variability in secondary prevention: a comparison of outpatients with a history of chronic coronary syndrome versus outpatients with a history of acute coronary syndrome (the iASPIRE Study).
    Curneen JM; Judge C; Traynor B; Buckley A; Saiva L; Murphy L; Murray D; Fleming S; Kearney P; Murphy RT; Aleong G; Kiernan TJ; O'Neill J; Moore D; Nicaodhabhui B; Birrane J; Hall P; Crowley J; Gibson I; Jennings CS; Wood D; Kotseva K; McEvoy JW
    Open Heart; 2021 Jun; 8(1):. PubMed ID: 34172561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated risk profile of women in secondary prevention of coronary artery disease: a 6-year survey of 117,913 patients.
    Reibis RK; Bestehorn K; Pittrow D; Jannowitz C; Wegscheider K; Völler H
    J Womens Health (Larchmt); 2009 Aug; 18(8):1123-31. PubMed ID: 19630543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.